• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Hep C Patent Ruling





Ha! Ha! Gilead stoled the science and now y'all have to pay --- Gilead Sciences Inc. has to pay Merck & Co. $2.54 billion in patent royalties!! You guys have been crooks in stealing a compound and then pricing it @ $84,000 to suck the blood out of patients. Karma is always there! Boycott all Gilead products!!